IMIM
DPLO

Irving Magee Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Irving Magee Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-166,505
Closed -$2.66M – 40
2017
Q1 		$2.66M Buy
+166,505
New +$2.4M 1.02% 49

Other funds holding DPLO

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Irving Magee Investment Management's DPLO Position: Q2 2017 in Review

Irving Magee Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2017, closing a stake of 166,505 shares — an estimated $2.66M sold.

Irving Magee Investment Management first reported a position in DPLO in Q1 2017 and held it in 1 quarter. The position peaked at $2.66M in Q1 2017. 175 funds tracked by Wall St. Rank hold DPLO as of Q2 2017.

  • Irving Magee Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2017 after selling out during the quarter.
  • Irving Magee Investment Management sold 166,505 DIPLOMAT PHARMACY, INC. shares in Q2 2017, an estimated $2.66M.
  • Irving Magee Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 1 quarter.
  • Irving Magee Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $2.66M in Q1 2017.
  • 175 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2017.

Based on Irving Magee Investment Management's 13F filing for Q2 2017.